Published in Ann Rheum Dis on November 01, 1995
Serological identification of fast progressors of structural damage with rheumatoid arthritis. Arthritis Res Ther (2013) 1.02
Matrix metalloproteinase-dependent turnover of cartilage, synovial membrane, and connective tissue is elevated in rats with collagen induced arthritis. J Transl Med (2012) 1.01
Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis. Clin Proteomics (2010) 0.93
Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip. Int Orthop (2004) 0.88
Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients? Clin Rheumatol (2007) 0.78
The value of synovial fluid analysis in the assessment of knee joint destruction in arthritis in a three year follow up study. Ann Rheum Dis (1999) 0.78
Procollagen propeptides in chronic subdural hematoma reveal sustained dural collagen synthesis after head injury. J Neurol (2009) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med (1968) 27.34
Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) (1977) 9.55
C-reactive protein in rheumatology. Arthritis Rheum (1991) 2.61
Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem (1993) 2.44
Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem (1988) 2.01
Radiologic assessment as an outcome measure in rheumatoid arthritis. Arthritis Rheum (1989) 1.37
Use of the radiograph to measure the course of rheumatoid arthritis. The gold standard versus fool's gold. Arthritis Rheum (1990) 1.34
Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis (1993) 1.05
Markers of bone and collagen breakdown in early inflammatory arthritis. Baillieres Clin Rheumatol (1992) 1.05
Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin North Am (1994) 1.04
Immunochemical markers of joint inflammation, skeletal damage and repair: where are we now? Ann Rheum Dis (1994) 1.02
Type I collagen degradation product in serum of patients with early rheumatoid arthritis: relationship to disease activity and radiological progression in a 3-year follow-up. Br J Rheumatol (1994) 0.98
Lymphatic clearance of synovial fluid in conscious pigs: the aminoterminal propeptide of type III procollagen. Eur J Clin Invest (1993) 0.97
Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis. Ann Rheum Dis (1993) 0.95
Serum amino-terminal type III procollagen peptide in rheumatoid arthritis. Relationship to disease activity, treatment, and development of joint erosions. Arthritis Rheum (1986) 0.91
Increased type I collagen degradation in early rheumatoid arthritis. J Rheumatol (1994) 0.86
Rheumatoid arthritis: can the long-term outcome be altered? Mayo Clin Proc (1988) 0.84
Evidence for simultaneous bidirectional fluid flux across synovial lining in knee joints of anaesthetized rabbits. Exp Physiol (1992) 0.84
The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis. Rheumatol Int (1988) 0.82
N-terminal procollagen peptide and beta 2-microglobulin in synovial fluids from inflammatory and non-inflammatory joint diseases. Clin Chim Acta (1984) 0.78
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet (1999) 4.98
Periradicular infiltration for sciatica: a randomized controlled trial. Spine (Phila Pa 1976) (2001) 3.53
European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology (2008) 2.67
Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem (1990) 2.51
Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem (1993) 2.44
Sexual functioning among stroke patients and their spouses. Stroke (1999) 2.32
7-S collagen: characterization of an unusual basement membrane structure. Eur J Biochem (1980) 2.19
Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet (1993) 2.09
Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem (1988) 2.01
Effect of gold treatment on the progression of erosions in RA patients. Scand J Rheumatol (1977) 2.01
Macromolecular structure of basement membrane collagens. FEBS Lett (1981) 1.96
Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. J Pediatr (1998) 1.94
Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles. Mol Microbiol (1990) 1.94
Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation (1997) 1.93
Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int (2001) 1.88
The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol (1989) 1.87
CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol (2005) 1.76
European guidelines for clinical management of abnormal cervical cytology, part 2. Cytopathology (2009) 1.74
Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol (2000) 1.71
The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res (2003) 1.68
Gene defect in hypodontia: exclusion of EGF, EGFR, and FGF-3 as candidate genes. J Dent Res (1996) 1.66
HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.61
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res (1993) 1.57
Finnish adoptive family study: sample selection and adoptee DSM-III-R diagnoses. Acta Psychiatr Scand (2000) 1.56
Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology (1990) 1.56
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer (1999) 1.56
Structural diversity and domain composition of a unique collagenous fragment (intima collagen) obtained from human placenta. Biochem J (1983) 1.55
Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol (1998) 1.53
Prolonged arthritis associated with sindbis-related (Pogosta) virus infection. Rheumatology (Oxford) (2000) 1.52
Central airways stenosis in school-aged children: differential diagnosis from asthma. Acta Paediatr (2002) 1.50
Biosynthesis of collagen and its alterations in pathological states. Med Biol (1976) 1.42
Collagen metabolites in the prediction of response to GH therapy in short children. Eur J Endocrinol (1997) 1.40
Variation among cardiologists in the utilization of right heart catheterization at time of coronary angiography. Cathet Cardiovasc Diagn (1996) 1.40
Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. Br J Cancer (2005) 1.37
Laminin. Methods Enzymol (1982) 1.37
Comorbidity of hospital-treated psychiatric and physical disorders with special reference to schizophrenia: a 28 year follow-up of the 1966 northern Finland general population birth cohort. Public Health (1998) 1.37
Comparison of GEANT4 very low energy cross section models with experimental data in water. Med Phys (2010) 1.35
Effect of gold on progression of erosions in rheumatoid arthritis. Better results with early treatment. Scand J Rheumatol (1977) 1.35
Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer (1992) 1.34
Assay of collagen-galactosyltransferase and collagen-glucosyltransferase activities and preliminary characterization of enzymic reactions with transferases from chick-embryo cartilage. Eur J Biochem (1975) 1.32
Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke (1999) 1.28
Atrial extracellular matrix remodelling in patients with atrial fibrillation. J Cell Mol Med (2008) 1.28
Bias against European journals in medical publication Databases. Lancet (1999) 1.28
Munc18-2, a functional partner of syntaxin 3, controls apical membrane trafficking in epithelial cells. J Biol Chem (2000) 1.27
Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol (1995) 1.27
Activities of prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase in the liver of rats with hepatic injury. Biochem J (1974) 1.25
Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection. Infect Immun (1992) 1.25
TNF signaling via the ligand-receptor pair ectodysplasin and edar controls the function of epithelial signaling centers and is regulated by Wnt and activin during tooth organogenesis. Dev Biol (2001) 1.24
Isolation and characterization of a variety of microcystins from seven strains of the cyanobacterial genus Anabaena. Appl Environ Microbiol (1992) 1.22
Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest (1985) 1.22
Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem (1996) 1.22
Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum (1996) 1.22
Cervical cancer screening programme in Finland. Eur J Cancer (2000) 1.21
Synthesis of type I collagen in healing wounds in humans. Ann Surg (1991) 1.19
Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun (2005) 1.19
Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest (1988) 1.19
Characteristics of incisor-premolar hypodontia in families. J Dent Res (2001) 1.18
Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis (2007) 1.18
Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum (1988) 1.18
Impact of cancer screening on women's health. Int J Gynaecol Obstet (1997) 1.17
Intestinal flora in early rheumatoid arthritis. Br J Rheumatol (1994) 1.16
Prolyl 3-hydroxylase: partial characterization of the enzyme from rat kidney cortex. Eur J Biochem (1977) 1.15
Novel mutation of the initiation codon of PAX9 causes oligodontia. J Dent Res (2005) 1.14
Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells. Biochem J (1990) 1.12
Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Bone (2000) 1.12
Domains and determinants of quality of life after stroke caused by brain infarction. Arch Phys Med Rehabil (2000) 1.12
Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum (1998) 1.12
Tooth morphogenesis and cell differentiation. Curr Opin Cell Biol (1996) 1.11
Isolation and characterization of pepsin fragments of laminin from human placental and renal basement membranes. Biochem J (1981) 1.10
Detection of herpesviruses by polymerase chain reaction in lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum (1993) 1.10
European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology. Cytopathology (2007) 1.09
Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations. Arthritis Rheum (2000) 1.09
Can we rely on magnetic resonance imaging when evaluating unstable atlantoaxial subluxation? Ann Rheum Dis (2003) 1.08
Aminoterminal propeptide of type III procollagen in serum during wound healing in human beings. Surgery (1990) 1.08
Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol (1993) 1.08
Partial purification and characterization of chick-embryo prolyl 3-hydroxylase. Biochem J (1979) 1.08
A new method to measure type I and III collagen synthesis in human skin in vivo: demonstration of decreased collagen synthesis after topical glucocorticoid treatment. J Invest Dermatol (1992) 1.07
Sindbis viruses and other alphaviruses as cause of human arthritic disease. J Intern Med (2004) 1.07
Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner (1994) 1.07
Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer. Br J Cancer (1995) 1.06